Front Page
Skip to content
Nashville, Tennessee, United States

News & Perspective

NashvilleGlobe.com

NashvilleGlobe.com Front Page · Article Archive

Technology ·

UK regulator develops early support for advanced medicines manufacturing

A November 18 MHRA release documents AdvanceGxP’s November 17 announcement and its planned testing phase.

Nashville Globe · News Desk

The UK medicines regulator is developing AdvanceGxP, a service intended to help manufacturers address regulatory and quality questions earlier in development. The initiative was announced at the DIA-MHRA Global Summit in London on November 17 and described in an official release November 18.

The Medicines and Healthcare products Regulatory Agency has secured Office for Life Sciences funding to develop and test the service. Its initial focus is advanced manufacturing, including personalised treatments made near hospitals, robotics, automation, artificial intelligence and manufacturing in space. Early specialist advice is intended to reduce avoidable redesign and delays as established manufacturing standards are applied to new technologies.

The funding will support recruitment of a specialist team and decisions about access, priorities and links with existing regulatory support. Initial capacity will be limited while the approach is tested. The announcement sets out development of an advisory service; it does not approve a medicine or establish that every proposed manufacturing technology has met regulatory requirements.